Search Results - yee+chan+li

1 Results Sort By:
Adoptive Transfer of CD49a TRM Stop and Reverse Lung Fibrosis
Value Proposition:·        Cellular therapy for the treatment of lung fibrosis with potential to stop and reverse underlying disease pathology.·        Improved efficacy and accessibility compared to status-quo therapies.·        Potential autologous therapy, as peripheral T cells can be used to induce this tissue resident memory subset.Technology Description....
Published: 5/10/2024   |   Inventor(s): Maureen Horton, Jonathan Powell, Samuel Collins, Yee Chan Li
Keywords(s):  
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Respiratory Diseases, Technology Classifications > Therapeutic Modalities > Cell Therapies
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum